Objective: To evaluate a fully automated system for liquid-based cytology (LBC): the NovaPrep® Processor System (NPS), which is based on the new concept of double decantation, versus conventional cytology (CC), the gold standard for cytology. Study Design: We performed a preliminary comparative study involving 1,129 female patients who underwent sampling for a Pap test; the sample was first smeared for CC and then, using the remaining specimen on the brush, for LBC with the NPS. The performances of CC and NPS were evaluated for accuracy and compared using the gold standard of a combination of one of the two methods of pathological cytology with screening for positive human papilloma virus, quantification of cells (normal and pathological), and improvement in the quality of samples and reading time. Results: The results showed improvement in sensitivity (3.81% for CC vs. 4.52% for NPS) with a specificity superior to 90% for both, a markedly decreased number of unsatisfactory specimens, notably samples containing too many inflamed cells (7.4% for CC vs. 0.5% for NPS), and a shortening of the reading time, which was three times less using NPS. Conclusion: This preliminary study showed a gain in sensitivity, a drop in the number of unsatisfactory specimens and a reduction in reading time with NPS. The results achieved using this fully automated LBC procedure are very promising and will hopefully reduce the overall cost of cervical cancer screening in the future.

Keywords:
Liquid-based cytology, Automation, Cervix, Screening
1.
Fahey MT, Irwing L, Macaskill P: Meta-analysis of Pap test accuracy. Am J Epidemiol 1995;141:680–689.
2.
Moriarty AT, Clayton AC, Zaleski S, Henry MR, Schwartz MR, Eversole GM, Tench WD, Fatheree LA, Souers RJ, Wilbur DC: Unsatisfactory reporting rates: 2006 practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Gynecologic Cytology. Arch Pathol Lab Med 2009;133:1912–1916.
3.
Voss JS, Kipp BR, Campion MB, Sokolova IA, Henry MR, Halling KC, Clayton AC: Comparison of fluorescence in situ hybridization, hybrid capture 2 and polymerase chain reaction for the detection of high-risk human papillomavirus in cervical cytology specimens. Anal Quant Cytol Histol 2009;31:208–216.
4.
Davey E, Barratt A, Chan SF, Mannes P, Saville AM: Effect of study design and quality unsatisfactory rates, cytology classifications, and accuracy in liquid-based versus conventional cervical cytology: a systemic review. Lancet 2006;367:122–132.
5.
Stoykova B, Kuzmanov G, Dowie R: Putting National Institute for Health and Clinical Excellence guidance into practice: a cost minimization model of a national roll-out of liquid-based cytology in England. Int J Technol Assess Health Care 2008;24:391–398.
6.
Herbert A, Johnson J: Personal view. Is it reality or an illusion that liquid-based cytology is better than conventional cervical smears? Cytopathology 2001;12:383–389.
7.
Karnon J, Peters J, Platt J, Chilcott J, McGoogan E, Brewer N: Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis. Health Technol Assess 2004;8:1–78.
8.
Payne N, Chilcota J, McGoogan E: Liquid-based cytology in cervical screening: a rapid and systematic review. Health Technol Assess 2000;4:1–73.
9.
Sherman ME: Future Directions in Cervical Pathology. J Natl Cancer Inst Monogr 2003;31:72–79.
10.
Chuck A: Cost-effectiveness of 21 alternative cervical cancer screening strategies. Value Health 2010;13:169–179.
11.
Prétet JL, Vidal C, Le Bail Carval K, Ramanah R, Carcopino X, Cartier I, Labouyrie E, Kantelip B, Coumes-Marquet S, Riethmuller D, Mougin C: Novaprep® Vial Test is a suitable liquid-based cytology medium for high risk human papillomavirus testing by Hybrid Capture 2. J Clin Virol 2010;49:286–289.
12.
Harper GJ: Contamination of the environment by special purpose centrifuges used in clinical laboratories. J Clin Pathol 1981;34:1114–1123.
13.
Bergbrant IM, Samuelsson L: PCR for monitoring HPV contamination of medical personnel during treatment of genital warts. Acta Derm Venereol 1994;74:393–395.
14.
Mendenhall WM, Logan HL: Human papillomavirus and head and neck cancer. Am J Clin Oncol, in press.
15.
Klein F, Kotb WA, Petersen I: Incidence of human papilloma virus in lung cancer. Lung Cancer 2009;65:13–18.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.